January 20, 2017 6:34 PM ET

Biotechnology

Company Overview of Acceleron Pharma Inc.

Key Executives for Acceleron Pharma Inc.

NameBoard RelationshipsTitleAge
Habib J. Dable 12 RelationshipsChief Executive Officer, President and Director47
Thomas P. Maniatis Ph.D.25 RelationshipsCo-Founder, Chairman of Scientific Advisory Board, Director and Member of Compensation Committee73
Mark Ptashne Ph.D.29 RelationshipsCo-Founder and Member of Scientific Advisory Board--
Kevin F. McLaughlin 9 RelationshipsChief Financial Officer, Senior Vice President and Treasurer60
Steven D. Ertel No RelationshipsChief Operating Officer and Executive Vice President47
View More Key Executives

Acceleron Pharma Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Francois Nader M.D., M.B.A. 57 RelationshipsAcceleron Pharma Inc.59
Habib J. Dable 12 RelationshipsAcceleron Pharma Inc.47
Thomas P. Maniatis Ph.D. 25 RelationshipsAcceleron Pharma Inc.73
Mark Ptashne Ph.D. 29 RelationshipsAcceleron Pharma Inc.--
Jean M. George 60 RelationshipsLightstone Ventures58
View All Board Members

Acceleron Pharma Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Terrence C. Kearney31 Relationships3 Executives
Compensation Committee Joseph S. Zakrzewski79 Relationships3 Executives
Nominating Committee Jean M. George60 Relationships3 Executives
Corporate Governance Committee Jean M. George60 Relationships3 Executives
Advisory Board Ph.D.Thomas P. Maniatis25 Relationships4 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
372.8K
Bonus
256.6K
Total Short Term Compensation
466.6K
Total Value of Options
34.4M
Compensation as of Fiscal Year
Acceleron Pharma Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Jiangsu Sihuan Bioengineering Co., Ltd Announces Executive Changes
January 20, 2017 4:31 AM ET
Polynovo Limited Appoints Gavin Smith as Joint Company Secretary
January 20, 2017 1:12 AM ET
Verastem, Inc. Announces Board Appointments
January 19, 2017 9:28 PM ET
AngioSoma, Inc. Announces Management Changes
January 19, 2017 7:46 PM ET
Ginkgo Bioworks Names Christian Henry to its Board of Directors
January 19, 2017 1:14 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Acceleron Pharma Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.